Sophia GeneticsSOPH +1.87%73 Buyback Yield % is -3.24 as of Jul. 07, 2026. GuruFocus rates SOPH with a GF Score™ of 73/100 and a GF Value™ of $5.05 (Fairly Valued). The stock has 6 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Sophia Genetics ranks worse than 68.73% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Sophia Genetics's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SOPH vs WEAV, NRC, MDRX: Buyback Yield % Comparison
For the Health Information Services subindustry, Sophia Genetics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sophia Genetics Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sophia Genetics's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Sophia Genetics's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sophia Genetics (SOPH) has a Buyback Yield % of -3.24 as of Jul. 07, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Sophia Genetics and its competitors. According to the industry distribution chart, Sophia Genetics ranks #189 out of 275 companies in the Healthcare Providers & Services industry, placing it in the top 68.7%.
Is Sophia Genetics' Buyback Yield % too high?
Sophia Genetics' current Buyback Yield % is -3.24. Based on the distribution chart, Sophia Genetics ranks #189 out of 275 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Sophia Genetics has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sophia Genetics' Buyback Yield % compare to WEAV and NRC?
According to the Healthcare Providers & Services industry distribution chart, Sophia Genetics ranks #189 out of 275 companies for Buyback Yield %. This places Sophia Genetics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Sophia Genetics and its competitors. Sophia Genetics's current Buyback Yield % is -3.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sophia Genetics stock overvalued right now?
Based on GuruFocus' analysis, Sophia Genetics (SOPH) is currently considered Fairly Valued. The stock's GF Value™ is $5.05, compared to a current price of $5.45 — trading 7.9% above its estimated fair value. The current Buyback Yield % is -3.24. Sophia Genetics' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Sophia Genetics (SOPH), the current Buyback Yield % is -3.24 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sophia Genetics (SOPH) Overvalued in 2026?
Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued.
The current stock price of $5.45 is trading 7.9% above its estimated GF Value™ of $5.05.
GuruFocus considers Sophia Genetics to be Fairly Valued.
Key valuation signals for SOPH:
Buyback Yield %: -3.24
GF Value™: $5.05 vs. price of $5.45 (7.9% above fair value)
No single metric tells the full story. See the SOPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
73GF Score
Get the complete analysis for SOPH
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SOPH has been successfully added to your 
